MGPI Q3'26 Earnings: revenue estimate is 119.70M USD

MGP Ingredients (MGPI) is expected to report Q3'26 earnings on October 28, with estimated revenue of 119.70M USD and EPS of 0.32 USD. The announcement is scheduled for 9:30 AM ET.

Original reporting
Published Oct 21, 2026, 11:00 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 21, 2026, 11:07 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
MGPI Q3'26 Earnings: revenue estimate is 119.70M USD — source image
Decision brief

The 30-second read

$MGPINeutralLow
01

Why it matters

The estimate sets expectations; any deviation in the actual results could trigger price moves.

02

Market read

Earnings preview for a micro‑cap; relevance primarily to MGPI shareholders and sector analysts.

03

What to watch

Potential hidden risks in MGPI's pipeline or supply chain that are not reflected in the estimate.

Relevance 5/10Novelty 5/10Timing: pre‑market on Oct 28

Background

MGPI is a specialty ingredients producer; the article previews its upcoming Q3 earnings.

Company-level read

Ticker impact

$MGPINeutralMedium confidence
Context

MGPI's Q3'26 earnings estimate of $119.7M revenue and $0.32 EPS is disclosed ahead of the Oct 28 release.

Expected impact

potential modest volatility as traders price in the estimate and await the actual report

Evidence & confidence

The article provides the first public estimate; investors may adjust positions but no concrete catalyst beyond the upcoming release.

Market effects

Provides a data point for the specialty chemicals sector ahead of earnings season.

Limited to U.S. small‑cap investors tracking MGPI.

Minimal; the company is micro‑cap with niche market exposure.

Counterpoint

If the estimate is overly optimistic, the stock could underperform on the actual release.

Key entities

  • MGP Ingredients, Inc.

    Issuer of the earnings estimate.

Related articles

$MGPIMed

MGP Ingredients’s Q3 earnings call: our top 5 analyst questions

MGP Ingredients reported Q3 revenue of $117.9M, missing estimates by 2.2%, but beat EPS estimates by 21.1%. CEO Julie Francis cited strategic execution and cost management as key to offsetting headwinds. The company reconfirmed full-year revenue guidance of $490M and raised EBITDA guidance to $94M. Analysts questioned distributor transitions, cost pressures, and competitive landscape. MGPI stock is up 14.1% since earnings.

$MGPIMed

MGP Ingredients Inc (MGPI) (Q3 2026) Earnings Call Highlights: Guidance Reaffirmed

MGP Ingredients (MGPI) reaffirmed its full-year guidance, with Q4 revenue expected between $140M-$150M. CEO Julie Francis cited strong demand and high capacity utilization. Branded Spirits gross margin fell 280 bps due to maintenance costs, but full-year outlook remains unchanged. Distributor cutover headwinds are expected to end by year's end. White goods growth is driven by premium offerings and new customer relationships.

$MGPIMed

MGP Ingredients (MGPI) Q3 2026 Earnings Call Transcript

MGP Ingredients (MGPI) reported Q3 2026 earnings, reducing debt by $28M and achieving a 3.6x leverage ratio. The company will rebrand to Sempraan, trading on NASDAQ under CASK. Q3 sales for Branded Spirits were $58.2M, down 4% YoY, while Distilling Solutions sales were $29M, down 29% YoY. The company expects continued growth and introduced new products and leadership frameworks.